US Stock MarketDetailed Quotes
TNDM Tandem Diabetes Care
- 31.220
- +1.180+3.93%
Close Nov 27 16:00 ET
- 31.250
- +0.030+0.10%
Post 16:23 ET
2.05BMarket Cap-16092P/E (TTM)
31.320High30.310Low824.55KVolume30.320Open30.040Pre Close25.58MTurnover1.27%Turnover RatioLossP/E (Static)65.68MShares53.69052wk High8.63P/B2.03BFloat Cap20.52052wk Low--Dividend TTM65.14MShs Float302.500Historical High--Div YieldTTM3.36%Amplitude2.140Historical Low31.017Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Tandem Diabetes Care Stock Forum
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!
As GLP-1 diet drug companies have grown in influence, they have grown to be the new leaders of the stock market.
$Novo-Nordisk A/S (NVO.US)$ , with Wegovy and Ozempic in hand, is now Europe's largest company with a market capitalization of $433 billion, and the Danish drug giant's rapid growth has even had a direct impact on the Danish krone exchange rate and interest rates.
Meanwhile, $Eli Lilly and Co (LLY.US)$ , whic...
No comment yet